Photodiagnosis Photodyn Ther:N-乙酰半胱氨酸防止由光动力治疗引起的脉络膜视网膜损伤

2018-04-26 cuiguizhong MedSci原创

韩国首尔国立大学医学院眼科的Kim TW近日在Photodiagnosis Photodyn Ther发表了他们近期的一项工作,他们在脉络膜新生血管(CNV)大鼠模型中,探讨了N-乙酰半胱氨酸(NAC)对由光动力治疗(PDT)引起的脉络膜视网膜损伤的保护作用。

韩国首尔国立大学医学院眼科的Kim TW近日在Photodiagnosis Photodyn Ther发表了他们近期的一项工作,他们在脉络膜新生血管(CNV)大鼠模型中,探讨了N-乙酰半胱氨酸(NAC)对由光动力治疗(PDT)引起的脉络膜视网膜损伤的保护作用。

在PDT治疗前7天,在24只Brown挪威大鼠中用氩激光诱导实验性CNV造模。从CNV诱导后1天开始,每天对NAC阳性组(12只大鼠)口服0.5mL NAC,并向NAC阴性组(12只大鼠)注射0.5mL生理盐水。在注射维替泊芬(PDT-)之前,在左眼进行42秒(总能量,25J / cm 2)的激光治疗,并且在这种输注(PDT +)之后15-20分钟,对右眼进行相同处理。在PDT和眼球摘除前进行荧光素血管造影以评估荧光素渗漏和CNV闭合情况。通过末端dUTP缺口末端标记(TUNEL)来评估PDT诱导的细胞凋亡情况,比较CNV厚度、荧光素血管造影数据和两组间切割的半胱天冬酶-3和超氧化物歧化酶(SOD)的免疫组织荧光染色的程度。

结果他们发现,激光治疗后14天,PDT治疗组的CNV闭合率显着高于对照组。然而,NAC阴性和NAC阳性组之间的CNV闭合率没有显着差异。在第1、3、7和14天,NAC- / PDT +中的视网膜细胞的TUNEL活性(用来衡量PDT诱导的细胞凋亡程度)高于NAC + / PDT +组。在第3天和第7天,在NAC-/PDT+中裂解的胱天蛋白酶-3和SOD水平比在NAC + / PDT +组中更高。

因此,他们认为,PDT可以引发氧自由基,进而诱导视网膜损伤和细胞凋亡。NAC可减少PDT对视网膜的损伤而不影响CNV的治疗效果。

原文出处:

Kim, T.W., J.W. Moon, and H.G. Yu, N-acetylcysteine Protects Against Chorioretinal Damage Induced by Photodynamic Therapy for Experimental Choroidal Neovascularization in a Rat Model. Photodiagnosis Photodyn Ther, 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2019-02-23 liuxiaona
  7. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2018-04-28 zutt
  8. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1719553, encodeId=0b971e195537c, content=<a href='/topic/show?id=404928e34f6' target=_blank style='color:#2F92EE;'>#光动力治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28734, encryptionId=404928e34f6, topicName=光动力治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c432763729, createdName=wshxjq, createdTime=Thu Aug 09 11:40:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054924, encodeId=1e8c2054924fe, content=<a href='/topic/show?id=e2365922f4' target=_blank style='color:#2F92EE;'>#diagnosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5922, encryptionId=e2365922f4, topicName=diagnosis)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Mar 04 00:40:00 CST 2019, time=2019-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638585, encodeId=be7116385854e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Sep 08 01:40:00 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687016, encodeId=4ecd168e016bb, content=<a href='/topic/show?id=5f688449023' target=_blank style='color:#2F92EE;'>#脉络膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84490, encryptionId=5f688449023, topicName=脉络膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15828309522, createdName=12498568m59暂无昵称, createdTime=Tue May 08 22:40:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735651, encodeId=c6341e35651e1, content=<a href='/topic/show?id=687923464ae' target=_blank style='color:#2F92EE;'>#乙酰半胱氨酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23464, encryptionId=687923464ae, topicName=乙酰半胱氨酸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=859133934050, createdName=yhj-time, createdTime=Wed Dec 19 13:40:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1788725, encodeId=559c1e8872555, content=<a href='/topic/show?id=ce4314201f3' target=_blank style='color:#2F92EE;'>#photo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14201, encryptionId=ce4314201f3, topicName=photo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Feb 23 18:40:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270047, encodeId=fa4112e00479a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397526, encodeId=4eff139e526a7, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546304, encodeId=2fa615463042a, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat Apr 28 14:40:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309738, encodeId=92ff309e3845, content=学习学习.了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Apr 27 08:25:25 CST 2018, time=2018-04-27, status=1, ipAttribution=)]
    2018-04-27 1dd8c52fm63(暂无匿称)

    学习学习.了解了解

    0

相关资讯

Crit Care:N-乙酰半胱氨酸和抗坏血酸能减少重症监护病人造影剂肾病吗?

由此可见,静脉注射N-乙酰半胱氨酸和抗坏血酸不能减少进行造影剂增强CT扫描的重症患者造影剂肾病发生,尽管治疗患者的8-异前列烷水平显着降低。

Schizophr Bull:如何用生物标记物介导精神分裂症治疗?

所有FDA批准的治疗精神分裂症的抗精神病药都拮抗多巴胺D2受体,因此需要找到新型精神分裂症治疗靶点。最近研究表明,氧化应激,特别是谷胱甘肽(GSH)系统的缺陷,在精神分裂症的病理生理中起作用。

J Thorac Dis:N-乙酰半胱氨酸及替加环素可有效对抗鲍曼不动杆菌的感染

鲍曼不动杆菌作为一种常见的机会性病原体,具有很强的生物膜形成能力,导致耐药性和慢性感染的发生。既往研究已经证明N-乙酰半胱氨酸(NAC)和替加环素(TGC)联合使用可协同抑制生物膜相关的细菌感染,包括耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌。本研究旨在探究NAC和TGC对鲍曼不动杆菌浮游细胞和生物膜的影响。 使用肉汤微量稀释法测定NAC的最小抑菌浓度(MICs)。通过结晶紫染色评估生物膜易感性

AIM:N-乙酰半胱氨酸和他汀类药物可减少造影剂肾病(CIN)

N-乙酰基半胱氨酸,碳酸氢钠,他汀类药物,和抗坏血酸已被研究用于减少造影剂肾病(CIN)。该研究的目的是评估接受造影的成年人中减少CIN干预措施的效果比较。研究人员在2015年6月检索了MEDLINE,EMBASE,Cochrane图书馆,ClinicalTrials.gov,和Scopus数据库。研究的风险偏差和整体证据的综合实力(SOE)被进行了评估。研究人员选择了N-乙酰半胱氨酸,碳酸氢钠,

Circulation:N-乙酰半胱氨酸对动脉血栓的有效溶栓作用!

动脉血栓形成期间的血小板交联涉及了血管性血友病因子(VWF)多聚体。因此,VWF的蛋白水解似乎有望分解富含血小板的血栓并恢复急性血栓障碍,如缺血性中风、急性冠状动脉综合征或急性肢体缺血的血管通畅。 N-乙酰半胱氨酸(NAC,临床批准的粘液溶解药物)可以减少大聚合蛋白中的链内二硫键。近期,一项发表在杂志Circulation上的研究检测了NAC能否在闭塞性血栓内切断VWF多聚体,从而导致其

Oncotarget:维生素D缺乏通过激发肝细胞中的氧化应激引起胰岛素抵抗

胰岛素抵抗是指各种原因使胰岛素促进葡萄糖摄取和利用的效率下降,机体代偿性的分泌过多胰岛素产生高胰岛素血症,以维持血糖的稳定。胰岛素抵抗易导致代谢综合征和2型糖尿病。研究表明,维生素D缺乏可导致胰岛素抵抗。维生素D3是维生素D在人体内主要的活性形式,1α-羟化酶是激活维生素D3合成的关键酶。发表于Oncotarget的一篇文章中,研究人员发现,维生素D缺乏诱导的胰岛素抵抗与肝细胞氧化应激有关。